Other News To Note
Wednesday, May 16, 2012
Furiex Pharmaceuticals Inc., of Morrisville, N.C., and Menarini Group, of Florence, Italy, said they entered a license deal giving Menarini rights to commercialize Priligy in Europe, most of Asia, Africa, Latin America and the Middle East, while Furiex will retain full development and commercialization rights in the U.S., Japan and Canada.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.